Biological therapy and neurological manifestations. What do we know?

Reumatol Clin. 2017 Mar-Apr;13(2):102-106. doi: 10.1016/j.reuma.2016.04.012. Epub 2016 Jun 28.
[Article in English, Spanish]

Abstract

Biological therapy has changed the course of inflammatory rheumatic diseases. The safety is well documented in national and international studies. Neurological manifestations are uncommon and it is difficult to establish a clear causal relationship. The neurological signs and symptoms that may appear are multiple and sometimes mimic demyelinating neurological diseases and/or neurodegenerative diseases. Knowledge and disclosure of these cases is essential for a comprehensive management of biological therapy in our patients.

Keywords: Anti-TNF alfa; Anti-TNF-alpha; Biological therapy; Enfermedades reumáticas inflamatorias; Inflammatory rheumatic diseases; Manifestaciones neurológicas; Neurological manifestations; Terapia biológica.

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Biological Therapy / adverse effects*
  • Humans
  • Nervous System Diseases / chemically induced*
  • Nervous System Diseases / diagnosis
  • Rheumatic Diseases / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha